Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects

Authors: Valentina Li Vecchi, Maurizio Soresi, Lydia Giannitrapani, Giovanni Mazzola, Sara La Sala, Fabio Tramuto, Giuseppe Caruso, Claudia Colomba, Pasquale Mansueto, Simona Madonia, Giuseppe Montalto, Paola Di Carlo

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

Despite the reported high prevalence of osteoporosis in the human immunodeficiency virus (HIV)-population, there have been no previous studies examining dairy calcium intake and bone mineral density (BMD) in HIV-subjects.
We assessed the prevalence of low BMD in HIV-infected and uninfected subjects and analyzed the effects of calcium intake, lifestyle and HIV-related risk factors on BMD.

Methods

One hundred and twelve HIV-infected subjects were consecutively enrolled. Seventy- six HIV-uninfected subjects matched for age and sex were enrolled as the control group. The HIV-subjects were interviewed about lifestyle habits and completed a weekly food-frequency questionnaire to estimate calcium intake. HIV-RNA, CD4+ T-cell count and data on antiretroviral therapy were also recorded. Both biochemical bone turnover markers and BMD, assessed by dual-energy radiographic absorptiometry (DXA) were recorded in the HIV-cases and controls. We also calculated the 10-year fracture risks using the WHO FRAX equation.

Results

Osteoporosis prevalence was significantly higher in the HIV-cases than controls (p < 0.05). BMI values were positively correlated with BMD (p < 0.05). Vitamin D levels were lower in the HIV-subjects (p < 0.02). No correlation was found with daily calcium intake.
BMI values were significantly correlated with dairy intake quartiles (p < 0.003). In HIV-subjects, the mean of FRAX score was 1.2 % for hip and 4.7 % for major osteoporotic fractures. On multivariate analysis of the lumbar spine DXA T-score, age (p < 0.005) and HIV/hepatitis C virus co-infection (p < 0.0001) were negatively correlated with BMD, while yogurt intake was a protective predictor of BMD (p < 0.05). In the femur DXA T-score, age (p < 0.01), nadir CD4 + T-cell count < 200 cells/μL (p < 0.05) and drug addiction ( p < 0.0001) were negatively correlated with BMD.

Conclusions

Among the foods rich in calcium, yogurt was a protective predictor of BMD in HIV-subjects. HIV/HCV co-infection, nadir CD4 + T-cell count < 200 cells/μL and drug addiction were independent predictors of severe BMD. Promoting behavioral changes in food intake and lifestyle, aimed at the primary prevention of bone disease in the chronically-infected subjects seems to be essential for implementing medical intervention in these cases.
Appendix
Available only for authorised users
Literature
2.
go back to reference Luxon BA: Bone disorders in chronic liver diseases. Curr Gastroenterol Rep. 2011, 13: 40-48. 10.1007/s11894-010-0166-4.CrossRefPubMed Luxon BA: Bone disorders in chronic liver diseases. Curr Gastroenterol Rep. 2011, 13: 40-48. 10.1007/s11894-010-0166-4.CrossRefPubMed
3.
go back to reference Goel V, Kar P: Hepatic osteodystrophy. Trop Gastroenterol. 2010, 31: 82-86.PubMed Goel V, Kar P: Hepatic osteodystrophy. Trop Gastroenterol. 2010, 31: 82-86.PubMed
4.
go back to reference Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L, Giustina A: Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab. 2008, 93: 4649-4655. 10.1210/jc.2008-0791.CrossRefPubMed Mazziotti G, Bianchi A, Bonadonna S, Cimino V, Patelli I, Fusco A, Pontecorvi A, De Marinis L, Giustina A: Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab. 2008, 93: 4649-4655. 10.1210/jc.2008-0791.CrossRefPubMed
5.
go back to reference Mancini T, Mazziotti G, Doga M, Carpinteri R, Simetovic N, Vescovi PP, Giustina A: Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone. 2009, 45: 784-788. 10.1016/j.bone.2009.06.006.CrossRefPubMed Mancini T, Mazziotti G, Doga M, Carpinteri R, Simetovic N, Vescovi PP, Giustina A: Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Bone. 2009, 45: 784-788. 10.1016/j.bone.2009.06.006.CrossRefPubMed
6.
go back to reference Martin TJ: Paracrine regulation of osteoclast formation and activity: milestones in discovery. J Musculoskelet Neuronal Interact. 2004, 4: 243-253.PubMed Martin TJ: Paracrine regulation of osteoclast formation and activity: milestones in discovery. J Musculoskelet Neuronal Interact. 2004, 4: 243-253.PubMed
7.
go back to reference Lima AL, de Oliveira PR, Plapler PG, Marcolino FM, de Souza Meirelles E, Sugawara A, Gobbi RG, Dos Santos AL, Camanho GL: Osteopenia and osteoporosis in people living with HIV: multiprofessional approach. HIV AIDS (Auckl). 2011, 3: 117-124. Lima AL, de Oliveira PR, Plapler PG, Marcolino FM, de Souza Meirelles E, Sugawara A, Gobbi RG, Dos Santos AL, Camanho GL: Osteopenia and osteoporosis in people living with HIV: multiprofessional approach. HIV AIDS (Auckl). 2011, 3: 117-124.
8.
go back to reference Musumeci M, Vadalà G, Tringali G, Insirello E, Roccazzello AM, Simpore J, Musumeci S: Genetic and environmental factors in human osteoporosis from Sub-Saharan to Mediterranean areas. J Bone Miner Metab. 2009, 27: 424-434. 10.1007/s00774-009-0041-2.CrossRefPubMed Musumeci M, Vadalà G, Tringali G, Insirello E, Roccazzello AM, Simpore J, Musumeci S: Genetic and environmental factors in human osteoporosis from Sub-Saharan to Mediterranean areas. J Bone Miner Metab. 2009, 27: 424-434. 10.1007/s00774-009-0041-2.CrossRefPubMed
9.
go back to reference Carmina E, Di Fede G, Napoli N, Renda G, Vitale G, Lo Pinto C, Bruno D, Malizia R, Rini GB: Hypogonadism and hormone replacement therapy on bone mass of adult women with thalassemia major. Calcif Tissue Int. 2004, 74: 68-71.CrossRefPubMed Carmina E, Di Fede G, Napoli N, Renda G, Vitale G, Lo Pinto C, Bruno D, Malizia R, Rini GB: Hypogonadism and hormone replacement therapy on bone mass of adult women with thalassemia major. Calcif Tissue Int. 2004, 74: 68-71.CrossRefPubMed
10.
go back to reference Alberti KG, Zimmet P, Shaw J, IDF epidemiology task force consensus group, IDF epidemiology task force consensus group: The metabolic syndrome-a new worldwide definition. Lancet. 2005, 366: 1059-1061. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed Alberti KG, Zimmet P, Shaw J, IDF epidemiology task force consensus group, IDF epidemiology task force consensus group: The metabolic syndrome-a new worldwide definition. Lancet. 2005, 366: 1059-1061. 10.1016/S0140-6736(05)67402-8.CrossRefPubMed
11.
go back to reference Varenna M, Binelli L, Casari S, Zucchi F, Sinigaglia L: Effects of dietary calcium intake on body weight and prevalence of osteoporosis in early postmenopausal women. Am J Clin Nutr. 2007, 86: 639-644.PubMed Varenna M, Binelli L, Casari S, Zucchi F, Sinigaglia L: Effects of dietary calcium intake on body weight and prevalence of osteoporosis in early postmenopausal women. Am J Clin Nutr. 2007, 86: 639-644.PubMed
12.
go back to reference Carnovale E, Marletta L: Food composition tables. 1997, Italian National Institute of Nutrition, Rome Carnovale E, Marletta L: Food composition tables. 1997, Italian National Institute of Nutrition, Rome
13.
go back to reference Krogh V, Freudenheim JL, D’Amicis A: Food sources of nutrients of the diet of elderly Italians: II Micronutrients. Int J Epidemiol. 1993, 22: 869-877. 10.1093/ije/22.5.869.CrossRefPubMed Krogh V, Freudenheim JL, D’Amicis A: Food sources of nutrients of the diet of elderly Italians: II Micronutrients. Int J Epidemiol. 1993, 22: 869-877. 10.1093/ije/22.5.869.CrossRefPubMed
14.
go back to reference Bonura F, Tramuto F, Vitale F, Perna AM, Viviano E, Romano N, Group for HIV-1 Antiretroviral Studies in Sicily, Group for HIV-1 Antiretroviral Studies in Sicily: Transmission of drug-resistant HIV type 1 strains in HAART-naive patients: a 5-year retrospective study in Sicily, Italy. AIDS Res Hum Retroviruses. 2010, 26: 961-965. 10.1089/aid.2009.0250.CrossRefPubMed Bonura F, Tramuto F, Vitale F, Perna AM, Viviano E, Romano N, Group for HIV-1 Antiretroviral Studies in Sicily, Group for HIV-1 Antiretroviral Studies in Sicily: Transmission of drug-resistant HIV type 1 strains in HAART-naive patients: a 5-year retrospective study in Sicily, Italy. AIDS Res Hum Retroviruses. 2010, 26: 961-965. 10.1089/aid.2009.0250.CrossRefPubMed
15.
go back to reference Focà E, Motta D, Borderi M, Gotti D, Albini L, Calabresi A, Izzo I, Bellagamba R, Narciso P, Sighinolfi L, Clò A, Gibellini D, Quiros-Roldan E, Brianese N, Cesana BM, Re MC, Torti C: Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infect Dis. 2012, 12: 38-10.1186/1471-2334-12-38.CrossRefPubMedPubMedCentral Focà E, Motta D, Borderi M, Gotti D, Albini L, Calabresi A, Izzo I, Bellagamba R, Narciso P, Sighinolfi L, Clò A, Gibellini D, Quiros-Roldan E, Brianese N, Cesana BM, Re MC, Torti C: Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infect Dis. 2012, 12: 38-10.1186/1471-2334-12-38.CrossRefPubMedPubMedCentral
16.
go back to reference Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Di Fede G, Rini GB: Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007, 92: 2500-2505. 10.1210/jc.2006-2725.CrossRefPubMed Carmina E, Bucchieri S, Esposito A, Del Puente A, Mansueto P, Di Fede G, Rini GB: Abdominal fat quantity and distribution in women with polycystic ovary syndrome and extent of its relation to insulin resistance. J Clin Endocrinol Metab. 2007, 92: 2500-2505. 10.1210/jc.2006-2725.CrossRefPubMed
17.
go back to reference Report of a WHO Study Group: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser. 1994, 843: 1-129. Report of a WHO Study Group: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser. 1994, 843: 1-129.
18.
go back to reference National Osteoporosis Foundation: Clinician’s Guide to Prevention and Treatment of Osteoporosis. 2010, National Osteoporosis Foundation, Washington, DC National Osteoporosis Foundation: Clinician’s Guide to Prevention and Treatment of Osteoporosis. 2010, National Osteoporosis Foundation, Washington, DC
19.
go back to reference Berry SD, Kiel DP, Donaldson MG, Cummings SR, Kanis JA, Johansson H, Samelson EJ: Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study. Osteoporos Int. 2010, 21: 53-60. 10.1007/s00198-009-1127-3.CrossRefPubMedPubMedCentral Berry SD, Kiel DP, Donaldson MG, Cummings SR, Kanis JA, Johansson H, Samelson EJ: Application of the National Osteoporosis Foundation Guidelines to postmenopausal women and men: the Framingham Osteoporosis Study. Osteoporos Int. 2010, 21: 53-60. 10.1007/s00198-009-1127-3.CrossRefPubMedPubMedCentral
21.
go back to reference Smit E, Graham NM, Tang A, Flynn C, Solomon L, Vlahov D: Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition. 1996, 12: 496-501. 10.1016/S0899-9007(96)91726-8.CrossRefPubMed Smit E, Graham NM, Tang A, Flynn C, Solomon L, Vlahov D: Dietary intake of community-based HIV-1 seropositive and seronegative injecting drug users. Nutrition. 1996, 12: 496-501. 10.1016/S0899-9007(96)91726-8.CrossRefPubMed
22.
go back to reference Leite LH, Sampaio AB: Dietary calcium, dairy food intake and metabolic abnormalities in HIV-infected individuals. J Hum Nutr Diet. 2010, 23: 535-543. 10.1111/j.1365-277X.2010.01068.x.CrossRefPubMed Leite LH, Sampaio AB: Dietary calcium, dairy food intake and metabolic abnormalities in HIV-infected individuals. J Hum Nutr Diet. 2010, 23: 535-543. 10.1111/j.1365-277X.2010.01068.x.CrossRefPubMed
23.
go back to reference Jacobson DL, Spiegelman D, Duggan C, Weinberg GA, Bechard L, Furuta L, Nicchitta J, Gorbach SL, Miller TL: Predictors of bone mineral density in human immunodeficiency virus-1 infected children. J Pediatr Gastroenterol Nutr. 2005, 41: 339-346. 10.1097/01.mpg.0000174468.75219.30.CrossRefPubMed Jacobson DL, Spiegelman D, Duggan C, Weinberg GA, Bechard L, Furuta L, Nicchitta J, Gorbach SL, Miller TL: Predictors of bone mineral density in human immunodeficiency virus-1 infected children. J Pediatr Gastroenterol Nutr. 2005, 41: 339-346. 10.1097/01.mpg.0000174468.75219.30.CrossRefPubMed
24.
go back to reference Lau EM, Suriwongpaisal P, Lee JK, De Das S, Festin MR, Saw SM, Khir A, Torralba T, Sham A, Sambrook P: Risk factors for hip fracture in Asian men and women: the Asian osteoporosis study. J Bone Miner Res. 2001, 16: 572-580. 10.1359/jbmr.2001.16.3.572.CrossRefPubMed Lau EM, Suriwongpaisal P, Lee JK, De Das S, Festin MR, Saw SM, Khir A, Torralba T, Sham A, Sambrook P: Risk factors for hip fracture in Asian men and women: the Asian osteoporosis study. J Bone Miner Res. 2001, 16: 572-580. 10.1359/jbmr.2001.16.3.572.CrossRefPubMed
25.
go back to reference Jha RM, Mithal A, Malhotra N, Brown EM: Pilot case–control investigation of risk factors for hip fractures in the urban Indian population. BMC Musculoskelet Disord. 2010, 11: 49-10.1186/1471-2474-11-49.CrossRefPubMedPubMedCentral Jha RM, Mithal A, Malhotra N, Brown EM: Pilot case–control investigation of risk factors for hip fractures in the urban Indian population. BMC Musculoskelet Disord. 2010, 11: 49-10.1186/1471-2474-11-49.CrossRefPubMedPubMedCentral
26.
go back to reference Johnell O, Gullberg B, Kanis JA, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Lopes Vaz A, Lyritis G: Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res. 1995, 10: 1802-1815.CrossRefPubMed Johnell O, Gullberg B, Kanis JA, Allander E, Elffors L, Dequeker J, Dilsen G, Gennari C, Lopes Vaz A, Lyritis G: Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study. J Bone Miner Res. 1995, 10: 1802-1815.CrossRefPubMed
27.
go back to reference Sahni S, Tucker KL, Kiel DP, Quach L, Casey V, Hannan MT: Positive Association of Total Dairy and Milk Intake with Bone Mineral Density (BMD): Results from the Framingham Offspring Study. 2011, The American Society for Bone and Mineral Research, Annual Meeting, San Diego, 19 September Sahni S, Tucker KL, Kiel DP, Quach L, Casey V, Hannan MT: Positive Association of Total Dairy and Milk Intake with Bone Mineral Density (BMD): Results from the Framingham Offspring Study. 2011, The American Society for Bone and Mineral Research, Annual Meeting, San Diego, 19 September
28.
go back to reference Sjögren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, Bäckhed F, Ohlsson C: The gut microbiota regulates bone mass in mice. J Bone Miner Res. 2012, 27: 1357-1367. 10.1002/jbmr.1588.CrossRefPubMedPubMedCentral Sjögren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, Bäckhed F, Ohlsson C: The gut microbiota regulates bone mass in mice. J Bone Miner Res. 2012, 27: 1357-1367. 10.1002/jbmr.1588.CrossRefPubMedPubMedCentral
29.
go back to reference Cunningham-Rundles S, Ahrné S, Johann-Liang R, Abuav R, Dunn-Navarra AM, Grassey C, Bengmark S, Cervia JS: Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients. 2011, 3: 1042-1070. 10.3390/nu3121042.CrossRefPubMedPubMedCentral Cunningham-Rundles S, Ahrné S, Johann-Liang R, Abuav R, Dunn-Navarra AM, Grassey C, Bengmark S, Cervia JS: Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection. Nutrients. 2011, 3: 1042-1070. 10.3390/nu3121042.CrossRefPubMedPubMedCentral
30.
go back to reference Nunnari G, Coco C, Pinzone MR, Pavone P, Berretta M, Di Rosa M, Schnell M, Calabrese G, Cacopardo B: The role of micronutrients in the diet of HIV-1-infected individuals. Front Biosci (Elite Ed). 2012, 4: 2442-2456.CrossRef Nunnari G, Coco C, Pinzone MR, Pavone P, Berretta M, Di Rosa M, Schnell M, Calabrese G, Cacopardo B: The role of micronutrients in the diet of HIV-1-infected individuals. Front Biosci (Elite Ed). 2012, 4: 2442-2456.CrossRef
31.
go back to reference Brown TT, Qaqish RB: Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006, 20: 2165-2174. 10.1097/QAD.0b013e32801022eb.CrossRefPubMed Brown TT, Qaqish RB: Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review. AIDS. 2006, 20: 2165-2174. 10.1097/QAD.0b013e32801022eb.CrossRefPubMed
32.
go back to reference Haug CJ, Aukrust P, Haug E, Mørkrid L, Müller F, Frøland SS: Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab. 1998, 83: 3832-3838. 10.1210/jc.83.11.3832.CrossRefPubMed Haug CJ, Aukrust P, Haug E, Mørkrid L, Müller F, Frøland SS: Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J Clin Endocrinol Metab. 1998, 83: 3832-3838. 10.1210/jc.83.11.3832.CrossRefPubMed
33.
go back to reference Conrado T, Miranda-Filho Dde B, Bandeira F: Vitamin D deficiency in HIV-infected individuals: one more risk factor for bone loss and cardiovascular disease?. Arq Bras Endocrinol Metabol. 2010, 54: 118-122.CrossRefPubMed Conrado T, Miranda-Filho Dde B, Bandeira F: Vitamin D deficiency in HIV-infected individuals: one more risk factor for bone loss and cardiovascular disease?. Arq Bras Endocrinol Metabol. 2010, 54: 118-122.CrossRefPubMed
34.
go back to reference Grund B, Peng G, Gibert CL, Hoy JF, Isaksson RL, Shlay JC, Martinez E, Reiss P, Visnegarwala F, Carr AD, INSIGHT SMART Body Composition Substudy Group, INSIGHT SMART Body Composition Substudy Group: Continuous antiretroviral therapy decreases bone mineral density. AIDS. 2009, 23: 1519-1529. 10.1097/QAD.0b013e32832c1792.CrossRefPubMedPubMedCentral Grund B, Peng G, Gibert CL, Hoy JF, Isaksson RL, Shlay JC, Martinez E, Reiss P, Visnegarwala F, Carr AD, INSIGHT SMART Body Composition Substudy Group, INSIGHT SMART Body Composition Substudy Group: Continuous antiretroviral therapy decreases bone mineral density. AIDS. 2009, 23: 1519-1529. 10.1097/QAD.0b013e32832c1792.CrossRefPubMedPubMedCentral
35.
go back to reference Bolland MJ, Grey A, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Gamble GD, Reid IR: Stable bone mineral density over six years in HIV-infected men treated with highly active anti-retroviral therapy (HAART). Clin Endocrinol (Oxf). in press Bolland MJ, Grey A, Horne AM, Briggs SE, Thomas MG, Ellis-Pegler RB, Gamble GD, Reid IR: Stable bone mineral density over six years in HIV-infected men treated with highly active anti-retroviral therapy (HAART). Clin Endocrinol (Oxf). in press
36.
go back to reference Jain RG, Lenhard JM: Select HIV protease inhibitors alter bone and fat metabolism ex vivo. J Biol Chem. 2002, 277: 19247-19250. 10.1074/jbc.C200069200.CrossRefPubMed Jain RG, Lenhard JM: Select HIV protease inhibitors alter bone and fat metabolism ex vivo. J Biol Chem. 2002, 277: 19247-19250. 10.1074/jbc.C200069200.CrossRefPubMed
37.
go back to reference Tan BM, Nelson RP, James-Yarish M, Emmnueal P, Schurman SJ: Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor. J Pediatr. 2001, 139: 447-451. 10.1067/mpd.2001.117005.CrossRefPubMed Tan BM, Nelson RP, James-Yarish M, Emmnueal P, Schurman SJ: Bone metabolism in children with human immunodeficiency virus infection receiving highly active anti-retroviral therapy including a protease inhibitor. J Pediatr. 2001, 139: 447-451. 10.1067/mpd.2001.117005.CrossRefPubMed
38.
go back to reference Fernández-Rivera J, García R, Lozano F, Macías J, García-García JA, Mira JA, Corzo JE, Gómez-Mateos J, Rueda A, Sánchez-Burson J, Pineda JA: Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clin Trials. 2003, 4: 337-346. 10.1310/4X0H-UVMJ-BHYW-CPFB.CrossRefPubMed Fernández-Rivera J, García R, Lozano F, Macías J, García-García JA, Mira JA, Corzo JE, Gómez-Mateos J, Rueda A, Sánchez-Burson J, Pineda JA: Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients. HIV Clin Trials. 2003, 4: 337-346. 10.1310/4X0H-UVMJ-BHYW-CPFB.CrossRefPubMed
39.
go back to reference McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL, Brown TT: Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis. 2010, 51: 937-946. 10.1086/656412.CrossRefPubMedPubMedCentral McComsey GA, Tebas P, Shane E, Yin MT, Overton ET, Huang JS, Aldrovandi GM, Cardoso SW, Santana JL, Brown TT: Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis. 2010, 51: 937-946. 10.1086/656412.CrossRefPubMedPubMedCentral
40.
go back to reference Yin MT, Overton ET: Increasing clarity on bone loss associated with antiretroviral initiation. J Infect Dis. 2011, 203: 1705-1707. 10.1093/infdis/jir184.CrossRefPubMed Yin MT, Overton ET: Increasing clarity on bone loss associated with antiretroviral initiation. J Infect Dis. 2011, 203: 1705-1707. 10.1093/infdis/jir184.CrossRefPubMed
41.
go back to reference Liu AY, Vittinghoff E, Sellmeyer DE, Irvin R, Mulligan K, Mayer K, Thompson M, Grant R, Pathak S, O'Hara B, Gvetadze R, Chillag K, Grohskopf L, Buchbinder SP: Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PLoS One. 2011, 6: e23688-10.1371/journal.pone.0023688.CrossRefPubMedPubMedCentral Liu AY, Vittinghoff E, Sellmeyer DE, Irvin R, Mulligan K, Mayer K, Thompson M, Grant R, Pathak S, O'Hara B, Gvetadze R, Chillag K, Grohskopf L, Buchbinder SP: Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco. PLoS One. 2011, 6: e23688-10.1371/journal.pone.0023688.CrossRefPubMedPubMedCentral
42.
go back to reference Torti C, Mazziotti G, Soldini PA, Focà E, Maroldi R, Gotti D, Carosi G, Giustina A: High prevalence of radiological vertebral fractures in HIV-infected males. Endocr. 2012, 41: 512-517. 10.1007/s12020-011-9586-7.CrossRef Torti C, Mazziotti G, Soldini PA, Focà E, Maroldi R, Gotti D, Carosi G, Giustina A: High prevalence of radiological vertebral fractures in HIV-infected males. Endocr. 2012, 41: 512-517. 10.1007/s12020-011-9586-7.CrossRef
43.
go back to reference Gazzaruso C: An increased risk for fractures: another cause of frailty in HIV-infected subjects. Endocrine. 2012, 41: 347-349. 10.1007/s12020-012-9640-0.CrossRefPubMed Gazzaruso C: An increased risk for fractures: another cause of frailty in HIV-infected subjects. Endocrine. 2012, 41: 347-349. 10.1007/s12020-012-9640-0.CrossRefPubMed
44.
go back to reference Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A: Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. J Infect Dis. 2009, 200: 1746-1754. 10.1086/644785.CrossRefPubMed Calmy A, Fux CA, Norris R, Vallier N, Delhumeau C, Samaras K, Hesse K, Hirschel B, Cooper DA, Carr A: Low bone mineral density, renal dysfunction, and fracture risk in HIV infection: a cross-sectional study. J Infect Dis. 2009, 200: 1746-1754. 10.1086/644785.CrossRefPubMed
45.
go back to reference Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P: Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2003, 36: 482-490. 10.1086/367569.CrossRefPubMed Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, Hoffmann M, Tebas P: Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2003, 36: 482-490. 10.1086/367569.CrossRefPubMed
46.
go back to reference Thomas J, Doherty SM: HIV infection–a risk factor for osteoporosis. J Acquir Immune Defic Syndr. 2003, 33: 281-291. 10.1097/00126334-200307010-00001.CrossRefPubMed Thomas J, Doherty SM: HIV infection–a risk factor for osteoporosis. J Acquir Immune Defic Syndr. 2003, 33: 281-291. 10.1097/00126334-200307010-00001.CrossRefPubMed
47.
go back to reference Bolland MJ, Grey AB, Gamble GD, Reid IR: CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab. 2007, 92: 4522-4528. 10.1210/jc.2007-1660.CrossRefPubMed Bolland MJ, Grey AB, Gamble GD, Reid IR: CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab. 2007, 92: 4522-4528. 10.1210/jc.2007-1660.CrossRefPubMed
48.
go back to reference Dougkas A, Reynolds CK, Givens ID, Elwood PC, Minihane AM: Associations between dairy consumption and body weight: a review of the evidence and underlying mechanisms. Nutr Res Rev. 2011, 24: 72-95. 10.1017/S095442241000034X.CrossRefPubMed Dougkas A, Reynolds CK, Givens ID, Elwood PC, Minihane AM: Associations between dairy consumption and body weight: a review of the evidence and underlying mechanisms. Nutr Res Rev. 2011, 24: 72-95. 10.1017/S095442241000034X.CrossRefPubMed
49.
go back to reference Warensjö E, Byberg L, Melhus H, Gedeborg R, Mallmin H, Wolk A, Michaëlsson K: Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ. 2011, 342: d1473-10.1136/bmj.d1473.CrossRefPubMedPubMedCentral Warensjö E, Byberg L, Melhus H, Gedeborg R, Mallmin H, Wolk A, Michaëlsson K: Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ. 2011, 342: d1473-10.1136/bmj.d1473.CrossRefPubMedPubMedCentral
50.
go back to reference Sharma A, Flom PL, Weedon J, Klein RS: Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS. 2010, 24: 2337-2345.CrossRefPubMedPubMedCentral Sharma A, Flom PL, Weedon J, Klein RS: Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS. 2010, 24: 2337-2345.CrossRefPubMedPubMedCentral
51.
go back to reference Etminani-Esfahani M, Khalili H, Soleimani N, Jafari S, Abdollahi A, Khazaeipour Z, Gholami K: Serum vitamin D concentration and potential risk factors for its deficiency in HIV positive individuals. Curr HIV Res. 2012, 10: 165-170. 10.2174/157016212799937272.CrossRefPubMed Etminani-Esfahani M, Khalili H, Soleimani N, Jafari S, Abdollahi A, Khazaeipour Z, Gholami K: Serum vitamin D concentration and potential risk factors for its deficiency in HIV positive individuals. Curr HIV Res. 2012, 10: 165-170. 10.2174/157016212799937272.CrossRefPubMed
52.
go back to reference Petta S, Ferraro D, Cammà C, Cabibi D, Di Cristina A, Di Marco V, Di Stefano R, Grimaudo S, Mazzola A, Levrero M, Scazzone C, Craxì A: Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antivir Ther. 2012, in press Petta S, Ferraro D, Cammà C, Cabibi D, Di Cristina A, Di Marco V, Di Stefano R, Grimaudo S, Mazzola A, Levrero M, Scazzone C, Craxì A: Vitamin D levels and IL28B polymorphisms are related to rapid virological response to standard of care in genotype 1 chronic hepatitis C. Antivir Ther. 2012, in press
53.
go back to reference Lo Re V, Guaraldi G, Leonard MB, Localio AR, Lin J, Orlando G, Zirilli L, Rochira V, Kostman JR, Tebas P: Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS. 2009, 23: 2191-2198. 10.1097/QAD.0b013e32832ec258.CrossRefPubMedPubMedCentral Lo Re V, Guaraldi G, Leonard MB, Localio AR, Lin J, Orlando G, Zirilli L, Rochira V, Kostman JR, Tebas P: Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men. AIDS. 2009, 23: 2191-2198. 10.1097/QAD.0b013e32832ec258.CrossRefPubMedPubMedCentral
Metadata
Title
Dairy calcium intake and lifestyle risk factors for bone loss in hiv-infected and uninfected mediterranean subjects
Authors
Valentina Li Vecchi
Maurizio Soresi
Lydia Giannitrapani
Giovanni Mazzola
Sara La Sala
Fabio Tramuto
Giuseppe Caruso
Claudia Colomba
Pasquale Mansueto
Simona Madonia
Giuseppe Montalto
Paola Di Carlo
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-192

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.